Liquidia Corporation
IPO
Just breathe
- Headquarters
- Morrisville, North Carolina
- Employees
- 51–200
- Founded
- 2004
- Business Model
- B2B
- Website
- liquidia.com
- Last Round
- Venture RoundJun 2025
About
Liquidia Corporation is a publicly traded biopharmaceutical company focused on developing and commercializing innovative therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH). The company leverages its proprietary PRINT nanotechnology platform to engineer inhaled therapies with enhanced efficacy and tolerability. Liquidia trades on Nasdaq as LQDA and is headquartered in Morrisville, North Carolina.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account